Oxygen: The good, the bad, and the necessary...

Thorax

Volumn 59, Issue 12, 2004, Pages 1005-1006

  Troosters, Thierry ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Ku Leuven ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; ISOPROSTANE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BREATHING; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITION; EDITORIAL; EXERCISE; HUMAN; HYPEROXIA; HYPOXEMIA; HYPOXIA; LUNG VASCULAR RESISTANCE; LUNG VENTILATION; OXIDATIVE STRESS; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; SMOKING HABIT; SURVIVAL; TREATMENT OUTCOME;

HUMANS; LONG-TERM CARE; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 9644275432     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.031617     Document Type: Editorial

References (21)

1. Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1:681-6.
2. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980;93:391-8.
3. Weitzenblum EA, Sautegeau M, Ehrhart M, et al. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985;131:493-8.
4. Zielinski JM, Tobiasz I, Hawrylkiewicz P, et al. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest 1998;113:65-70.
5. Gorecka DK, Gorzelak P, Sliwinski M, et al. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997;52:674-9.
6. Somfay AJ, Porszasz S, Lee M, et al. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J 2001;18:77-84.
7. Heaton RK, Grant I, McSweeny AJ, et al. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1983;143:1941-7.
8. Eaton TC, Lewis P, Young Y, et al. Long-term oxygen therapy improves health-related quality of life. Respir Med 2004;98:285-93.
9. National Institute for Clinical Excellence (NICE). Chronic obstructive pulmonary disease: national clinical guideline for the management of COPD in adults in primary and secondary care. Thorax 2004;59(Suppl 1).
10. Emtner MJ, Porszasz M, Burns A, et al. Benefits of supplemental oxygen in rehabilitative exercise training in non-hypoxemic COPD patients. Eur Respir J 2002;20:235s.
11. Calverley PM. Supplementary oxygen therapy in COPD: is it really useful? Thorax 2000;55:537-8.
12. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, et al. Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax 2004;59:1016-19.
13. Van Hoydonck PG, Wuyts WA, Vanaudenaerde BM, et al. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J 2004;23:189-92.
14. Rahman I. Reproducibility of oxidative stress biomarkers in breath condensate: are they reliable? Eur Respir J 2004;23:183-4.
15. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, et al. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 2003;21:589-93.
16. Reid MB. COPD as a muscle disease. Am J Respir Crit Care Med 2001;164:1101-5.
17. 2 therapy. J Appl Physiol 1996;81:2198-202.
18. Carpagnano GE, Kharitonov SA, Resta O, et al. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 2002;122:1162-7.
19. Takabatake NH, Nakamura S, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1179-84.
20. Schols AM, Slangen J, Volovics L, et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-7.
21. Coursin DB, Cihla HP, Will JA, et al. Adaptation to chronic hyperoxia. Biochemical effects and the response to subsequent lethal hyperoxia. Am Rev Respir Dis 1987;135:1002-6.